Measuring pharmacodynamic endpoints accurately is critical to advancing compounds toward clinical trials. While methods such as ELISA, RT-PCR, and western blotting are widely used, Meso Scale Discovery (MSD) immunoassays offer a compelling advantage in sensitivity,...
